researchJournal article published
Peer-reviewed research on human placental extract and NEC.
Read source +IDEAS TO EVIDENCE.
PROGRESS TO SHARE.
Research publications and company updates from Plakous Therapeutics.
research
companyNIH funding renewal
The company’s Phase IIB SBIR funding update.
Read source +
companyNew board member
James Kalinovich joins Plakous’s Board of Directors.
Read source +
companyMayo Clinic agreement
A know-how license agreement supporting the company’s research.
Read source +
companyFDA development designations
Orphan drug and rare pediatric disease designations for Protego-PD.
Read source +
companyNCBiotech support
Support from the North Carolina Biotechnology Center.
Read source +